-
Historical Archive
EU fines: 93 million and 800 thousand euros for LUNDBECK
EU fines: LUNDBECK 93 million and 800 thousand euros The European Commission has fined the Danish pharmaceutical company Lundbeck for…
Leggi » -
Historical Archive
Sick abroad from October for innovative drugs at NHS expense
There is no innovative drug in Italy. In France, Germany or Austria yes. And if you currently need a permit from the…
Leggi » -
Historical Archive
-
Historical Archive
Fake drug for children, Nas: investigation born from a report from a pharmacist
It was a pharmacist in Rome who reported to the pharmacovigilance system the inadequate and suspected consistency of the drug (Ozopulmin)…
Leggi » -
Historical Archive
-
Historical Archive
Counterfeit medicines for children: three arrests "If you have Ozopulmin at home, don't use it"
The accusation is having marketed a medicine without an active ingredient in order not to lose market share. Executives at…
Leggi » -
Historical Archive
Antitrust. The pharmaceutical sector remains among the most sanctioned. Abuse and instrumental use of the patent
This is what emerged from the annual report of the Authority for competition and the market presented today in Parliament. The Guarantor is…
Leggi » -
Historical Archive
US Court, companies citable for 'pay-for-delay' agreements
Pharmaceutical companies can be sued for paying rival companies to delay getting to market…
Leggi » -
Historical Archive
Di Iorio (Naples): lack of drugs, poor image and service
The shortage of drugs in the pharmacies of Naples impoverishes the image of the pharmacy in the eyes of the patient and makes the…
Leggi » -
Historical Archive